Reportlinker Adds North America Neurology Devices Market Outlook to 2017

NEW YORK, April 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

North America Neurology Devices Market Outlook to 2017

http://www.reportlinker.com/p0336547/North-America-Neurology-Devices-Market-Outlook-to-2017.html

North America Neurology Devices Market Outlook to 2017

Summary

GlobalData's new report, "North America Neurology Devices Market Outlook to 2017" provides key market data on the North America Neurology Devices market –United States and Canada. The report provides value (USD million) data for all the market categories – Interventional Neurology, Neurological Diagnostic Equipment, CSF Management, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include United States and Canada.

- Market size and company share data for Neurology Devices market categories – Interventional Neurology, Neurological Diagnostic Equipment, CSF Management, Neurostimulation Devices, Neurosurgical Products and Radiosurgery

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the North America Neurology Devices market..

- Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Cyberonics, Inc., DePuy, Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the North America Neurology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 9

1.2 List of Figures 11

2 Introduction 13

2.1 What is This Report About? 13

3 Neurology Devices in North America 14

3.1 Neurology Devices Cross Country Comparison, Revenue ($m), 2003-2017 14

3.2 Neurology Devices, North America, Overall Revenue ($m), 2003-2017 15

3.3 Neurology Devices, North America, Category Volume (Units), 2003-2017 22

3.4 Neurology Devices, North America, Company share (2009-2010) 27

4 Neurology Devices In United States 29

4.1 Neurology Devices, United States, Overall Revenue ($m), 2003-2017 29

4.2 Neurology Devices, United States, Category Volume (Units), 2003-2017 35

4.3 Neurology Devices, United States, Distribution Share (2009-2010) 41

4.3.1 CSF Management, United States, Distribution Share (2009-2010) 41

4.3.2 Interventional Neurology, United States, Distribution Share (2009-2010) 41

4.3.3 Neurological Diagnostic Equipment, United States, Distribution Share (2009-2010) 42

4.3.4 Neurostimulation Devices, United States, Distribution Share (2009-2010) 42

4.3.5 Neurosurgical Products, United States, Distribution Share (2009-2010) 43

4.3.6 Radiosurgery, United States, Distribution Share (2009-2010) 43

4.4 Neurology Devices, United States, Company Share (2009-2010) 44

4.4.1 Neurology Devices, United States, Company Share (2009-2010) 44

4.4.2 CSF Management, United States, Company Share (2009-2010) 46

4.4.3 Interventional Neurology, United States, Company Share (2009-2010) 47

4.4.4 Neurological Diagnostic Equipment, United States, Company Share (2009-2010) 49

4.4.5 Neurostimulation Devices, United States, Company Share (2009-2010) 51

4.4.6 Neurosurgical Products, United States, Company Share (2009-2010) 53

4.4.7 Radiosurgery, United States, Company Share (2009-2010) 55

5 Neurology Devices In Canada 56

5.1 Neurology Devices, Canada, Overall Revenue ($m), 2003-2017 56

5.2 Neurology Devices, Canada, Category Volume (Units), 2003-2017 62

5.3 Neurology Devices, Canada, Distribution Share (2009-2010) 67

5.3.1 CSF Management, Canada, Distribution Share (2009-2010) 67

5.3.2 Interventional Neurology, Canada, Distribution Share (2009-2010) 67

5.3.3 Neurological Diagnostic Equipment, Canada, Distribution Share (2009-2010) 68

5.3.4 Neurostimulation Devices, Canada, Distribution Share (2009-2010) 68

5.3.5 Neurosurgical Products, Canada, Distribution Share (2009-2010) 69

5.3.6 Radiosurgery, Canada, Distribution Share (2009-2010) 69

5.4 Neurology Devices, Canada, Company Share (2009-2010) 70

5.4.1 Neurology Devices, Canada, Company Share (2009-2010) 70

5.4.2 CSF Management, Canada, Company Share (2009-2010) 72

5.4.3 Interventional Neurology, Canada, Company Share (2009-2010) 74

5.4.4 Neurological Diagnostic Equipment, Canada, Company Share (2009-2010) 76

5.4.5 Neurostimulation Devices, Canada, Company Share (2009-2010) 78

5.4.6 Neurosurgical Products, Canada, Company Share (2009-2010) 80

5.4.7 Radiosurgery, Canada, Company Share (2009) 82

6 Overview of Key Companies in North America Neurology Devices Market 83

6.1 Medtronic, Inc. 83

6.1.1 Company Overview 83

6.1.2 Share in the North America Neurology Devices Market 83

6.2 Boston Scientific Corporation 84

6.2.1 Company Overview 84

6.2.2 Share in the North America Neurology Devices Market 84

6.3 St. Jude Medical, Inc. 85

6.3.1 Company Overview 85

6.3.2 Share in the North America Neurology Devices Market 85

6.4 Cyberonics, Inc. 86

6.4.1 Company Overview 86

6.4.2 Share in the North America Neurology Devices Market 86

6.5 DePuy, Inc. 87

6.5.1 Company Overview 87

6.5.2 Share in the North America Neurology Devices Market 87

6.6 Integra LifeSciences Holdings Corporation 88

6.6.1 Company Overview 88

6.6.2 Share in the North America Neurology Devices Market 88

6.7 CareFusion Corporation 89

6.7.1 Company Overview 89

6.7.2 Share in the North America Neurology Devices Market 89

6.8 Accuray Incorporated 90

6.8.1 Company Overview 90

6.9 Cadwell Laboratories, Inc. 90

6.9.1 Company Overview 90

6.10 Covidien plc 90

6.10.1 Company Overview 90

6.11 Natus Medical Incorporated 91

6.11.1 Company Overview 91

6.12 ev3 Inc. 91

6.12.1 Company Overview 91

6.13 Elekta AB 91

6.13.1 Company Overview 91

6.14 Micrus Endovascular Corporation 92

6.14.1 Company Overview 92

6.15 B. Braun Melsungen AG 92

6.15.1 Company Overview 92

6.16 Terumo Corporation 92

6.16.1 Company Overview 92

6.17 Nihon Kohden Corporation 93

6.17.1 Company Overview 93

6.18 KARL STORZ GmbH & Co. KG 93

6.18.1 Company Overview 93

6.19 Sophysa S.A. 93

6.19.1 Company Overview 93

7 Neurology Devices Market Pipeline Products 94

8 Financial Deals Landscape 101

8.1 Acquisition 101

8.1.1 Impulse Monitoring Acquires Great Lakes Intraoperative Neuromonitoring 101

8.1.2 Boston Scientific Acquires Remaining Stake In Intelect Medical 102

8.1.3 Vycor Medical Completes Acquisition Of NovaVision 104

8.1.4 Synthes Acquires The Anspach Effort 105

8.1.5 Stryker Acquires Porex Surgical 106

8.1.6 Cardinal Health Sells 13.7% Stake In Carefusion 107

8.1.7 HealthMed Services Acquires Neural Communicator 108

8.1.8 Masimo Completes Acquisition Of SEDLine 109

8.1.9 Johnson & Johnson Completes Acquisition Of Micrus Endovascular 110

8.1.10 K-Kitz Acquires Bacterin In Reverse Acquisition 112

8.1.11 Medtronic Acquires Axon Systems 113

8.1.12 Covidien Completes Acquisition Of ev3 For $2.6 Billion 114

8.2 Partnerships 116

8.2.1 Boston Scientific Enters Into Partnership With Greatbatch Medical 116

8.2.2 Synergetics USA Enters Into Co-Development Agreement With Retinal Solutions 117

8.2.3 EndoStim Enters Into an Agreement With Arizona State University 118

9 Recent Developments 119

9.1 Strategy and Business Planning 119

9.1.1 Jan 04, 2011: NeuroMetrix To Shift Business Focus To Diabetes 119

9.1.2 Dec 17, 2010: Accuray Establishes Medical Affairs Function 120

9.1.3 Nov 09, 2010: Medtronic Opens New Distribution Center In Elizabeth, New Jersey 120

9.1.4 Nov 02, 2010: InVivo Therapeutics Opens New Manufacturing And Development Facility In Medford, Massachusetts 120

9.1.5 Oct 21, 2010: Collagen Matrix Expands Operations And Moves Corporate Headquarters To Oakland, New Jersey 121

9.1.6 Aug 26, 2010: Pico-Tesla Opens New Facility In Michigan 121

9.1.7 Aug 24, 2010: Cyberonics Signs Epilepsy Technology Agreements With NeuroVista In Field Of EEG-based Seizure Detection 122

9.1.8 Aug 20, 2010: Integra Opens Center For Research, Education And Training In Irvine, California 122

9.1.9 Aug 19, 2010: Boston Scientific To Invest In New Products: CEO 123

9.1.10 Aug 10, 2010: CareFusion Announces Company-Wide Restructuring 123

9.1.11 Jun 02, 2010: B. Braun Announces Construction Of New Infusion Technology Facility In Melsungen, Germany 123

9.1.12 May 06, 2010: Swedish Cancer Institute And Elekta Renew Partnership Agreement 124

9.1.13 Apr 20, 2010: Siemens Opens National Customer Service Headquarters For 24x7 Service And Support 124

9.2 Legal and Regulatory 125

9.2.1 Jan 20, 2011: St. Jude Medical Reaches Settlement With DOJ 125

9.2.2 Jan 11, 2011: Boston Scientific Reaches Settlement With Medinol 125

9.2.3 Dec 09, 2010: Medtronic Receives Subpoena From US Government For Certain Neurostimulation Devices 125

9.2.4 Nov 10, 2010: St. Jude Medical And AGA Medical Announce Early Termination Of HSR Waiting Period 125

9.2.5 Nov 02, 2010: CSI Settles Employee Lawsuit With ev3 126

9.2.6 Sep 23, 2010: St. Jude Medical Faces Derivative Suit From Shareholders 126

9.2.7 Aug 10, 2010: Best Medical Files Patent Infringement Lawsuit Against Accuray 126

9.2.8 Jul 12, 2010: Law Offices Of Howard G. Smith Investigates Micrus Acquisition For Shareholders 126

9.2.9 Jul 06, 2010: ev3 Agrees To Settle Stockholder Litigation 127

9.2.10 Jun 01, 2010: Finkelstein Thompson LLP Announces Investigation Of ev3 127

9.2.11 Apr 09, 2010: Robbins Geller Files Class Action Suit Against Boston Scientific 127

9.3 Government and Public Interest 128

9.3.1 Feb 16, 2011: University Of Minnesota Researchers Receive $3m Grants To Create Robotic Devices And Computer Vision Algorithms For Early Detection Of Childhood Mental Disorders 128

9.3.2 Feb 15, 2011: Mayo Clinic Researchers Develop WINCS Device To Measure Brain Chemistry During Deep Brain Stimulation 129

9.3.3 Jan 24, 2011: Deep Brain Stimulation May Help Hard-To-Control High Blood Pressure: Case Study 130

9.3.4 Jan 18, 2011: Stents Help Stroke Victims When Other Treatments Fails: Research At ISET 130

9.3.5 Dec 21, 2010: Boston Scientific Receives Notices Of Deficiency From IRS 131

9.3.6 Dec 16, 2010: Researchers Suggest Diagnostic Criteria For Posttraumatic Stress Disorder Are Lacking 131

9.3.7 Nov 29, 2010: Neuro Kinetics Earns Approval From Health Canada To Sell Diagnostic Devices In Canada 132

9.3.8 Nov 14, 2010: Mental Introspection Increases As Brain Areas Begin To Act In Sync: Georgetown University Medical Center 132

9.3.9 Oct 25, 2010: Radiation Therapy Improves Painful Condition Associated With MS: ASTRO 133

9.3.10 Oct 08, 2010: Senator Grassley Questions VA Official's Relationship With Medtronic 134

9.3.11 Oct 06, 2010: Salk Researchers Map Functional Connections Between Retinal Neurons At Single-Cell Resolution 134

9.3.12 Sep 24, 2010: Scarless Brain Surgery Is New Option For Patients: UCSD And University Of Washington Study 136

9.3.13 Sep 14, 2010: FDA Advisory Committee To Discuss Clinical Trial Design Issues For Neurological Devices 136

9.3.14 Sep 08, 2010: SMU-Led Research Center Aims To Connect Brain Signals To Robotic Limbs 137

9.3.15 Aug 25, 2010: Research Heralds Potential For Early Diagnosis Of Degenerative Brain Disorders 138

9.3.16 Aug 22, 2010: Gene Scan Finds Link Across Array Of Childhood Brain Disorders 139

9.3.17 Aug 11, 2010: Boston Scientific Resolves Corporate Warning Letter 140

9.3.18 Jul 22, 2010: Stanford University School Of Medicine Seeks Patient Enrollment For Alzheimer's Study 140

9.3.19 Jul 12, 2010: MRI Better Than CT Scans At Diagnosing Stroke: New Guideline 141

9.3.20 Jun 30, 2010: New Study Identifies Best Tests For Predicting Alzheimer's Disease: Study 141

9.3.21 Jun 22, 2010: UCLA Brain Scanning Study Has Implications For Advertising, Public Health Campaigns 142

9.3.22 Jun 03, 2010: Governor Designates Cleveland Health And Technology Corridor An Ohio Hub Of Innovation And Opportunity 143

9.3.23 May 11, 2010: Stereotactic Radiosurgery Is Safe And Effective For Selected Children With Arteriovenous Malformations: Mayo Clinic 145

9.3.24 May 04, 2010: Stereotactic Radiosurgery Successful For Most Patients With Large Acoustic Neuromas: Mayo Clinic 145

9.3.25 May 03, 2010: Imaging Study Discovers Brain Development Differences In Kids With Fragile X Syndrome: Study 146

9.3.26 Apr 30, 2010: Tiny Particles May Help Surgeons By Marking Brain Tumors 147

9.3.27 Apr 19, 2010: Surgeons Use Brain Port Device To Treat Brain Cyst 148

9.3.28 Apr 18, 2010: Scientists Develop Brain-Recording Device To Control Seizures 149

9.3.29 Apr 16, 2010: Clinical Study Shows Patients Gain Limb Movement Years After Stroke 150

9.3.30 Apr 09, 2010: CDRH: Research Needed To Explore Side Effects Of Pediatric Devices 151

9.3.31 Apr 01, 2010: UC Researchers Quantify Benefits Of Minimally Invasive Removal For Tumors 151

9.4 Product News 153

9.4.1 Aug 10, 2010: NKI To Present Two Research Studies On I-Portal NOTC System At Barany Society Conference 153

9.4.2 Jul 15, 2010: Elekta To Highlight Intelligent Cancer Management Solutions At 2010 AAPM Annual Meeting 153

9.4.3 May 05, 2010: Terumo Announces Its Program For The Global Embolization Symposium And Technologies (GEST) Meeting 154

10 Appendix 155

10.1 Definitions of Markets Covered in the Report 156

10.1.1 Neurology Devices 156

10.2 Research Methodology 157

10.3 Secondary Research 157

10.4 Primary Research 158

10.5 Models 158

10.6 Forecasts 159

10.7 Expert Panels 159

10.8 GlobalData Consulting 159

10.9 Currency Conversion 160

10.10 Contact Us 160

10.11 Disclaimer 160

1.1 List of Tables

Table 1: Neurology Devices, Cross Country Comparison, Revenue ($m), 2003-2017 14

Table 2: Neurology Devices, North America, Overall Revenue ($m), 2003-2017 16

Table 3: Neurology Devices, North America, Cross-Category Analysis, 2003-2017 17

Table 4: Neurology Devices, North America, Overall Revenue ($m), Historic, 2003-2010 19

Table 5: Neurology Devices, North America, Overall Revenue ($m), Forecast, 2010-2017 21

Table 6: Neurology Devices, North America, Category Volume (Units), 2003-2017 22

Table 7: Neurology Devices, North America, Category Volume (Units), Historic, 2003-2010 24

Table 8: Neurology Devices, North America, Category Volume (Units), Forecast, 2010-2017 26

Table 9: Neurology Devices, North America, Company share by Revenue ($m), 2009-2010 28

Table 10: Neurology Devices, United States, Overall Revenue ($m), 2003-2017 30

Table 11: Neurology Devices, United States, Overall Revenue ($m), Historic, 2003-2010 32

Table 12: Neurology Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 34

Table 13: Neurology Devices, United States, Category Volume (Units), 2003-2017 35

Table 14: Neurology Devices, United States, Category Volume (Units), Historic, 2003-2010 37

Table 15: Neurology Devices, United States, Category Volume (Units), Forecast, 2010-2017 39

Table 16: CSF Management, United States, Distribution Share by Revenue ($m), 2009-2010 41

Table 17: Interventional Neurology, United States, Distribution Share by Revenue ($m), 2009-2010 41

Table 18: Neurological Diagnostic Equipment, United States, Distribution Share by Revenue ($m), 2009-2010 42

Table 19: Neurostimulation Devices, United States, Distribution Share by Revenue ($m), 2009-2010 42

Table 20: Neurosurgical Products, United States, Distribution Share by Revenue ($m), 2009-2010 43

Table 21: Radiosurgery, United States, Distribution Share by Revenue ($m), 2009-2010 43

Table 22: Neurology Devices, United States, Company Share by Revenue ($m), 2009-2010 45

Table 23: CSF Management, United States, Company Share by Revenue ($m), 2009-2010 46

Table 24: Interventional Neurology, United States, Company Share by Revenue ($m), 2009-2010 48

Table 25: Neurological Diagnostic Equipment, United States, Company Share by Revenue ($m), 2009-2010 50

Table 26: Neurostimulation Devices, United States, Company Share by Revenue ($m), 2009-2010 52

Table 27: Neurosurgical Products, United States, Company Share by Revenue ($m), 2009-2010 54

Table 28: Radiosurgery, United States, Company Share by Revenue ($m), 2009-2010 55

Table 29: Neurology Devices, Canada, Overall Revenue ($m), 2003-2017 57

Table 30: Neurology Devices, Canada, Overall Revenue ($m), Historic, 2003-2010 59

Table 31: Neurology Devices, Canada, Overall Revenue ($m), Forecast, 2010-2017 61

Table 32: Neurology Devices, Canada, Category Volume (Units), 2003-2017 62

Table 33: Neurology Devices, Canada, Category Volume (Units), Historic, 2003-2010 64

Table 34: Neurology Devices, Canada, Category Volume (Units), Forecast, 2010-2017 66

Table 35: CSF Management, Canada, Distribution Share by Revenue ($m), 2009-2010 67

Table 36: Interventional Neurology, Canada, Distribution Share by Revenue ($m), 2009-2010 67

Table 37: Neurological Diagnostic Equipment, Canada, Distribution Share by Revenue ($m), 2009-2010 68

Table 38: Neurostimulation Devices, Canada, Distribution Share by Revenue ($m), 2009-2010 68

Table 39: Neurosurgical Products, Canada, Distribution Share by Revenue ($m), 2009-2010 69

Table 40: Radiosurgery, Canada, Distribution Share by Revenue ($m), 2009 69

Table 41: Neurology Devices, Canada, Company Share by Revenue ($m), 2009-2010 71

Table 42: CSF Management, Canada, Company Share by Revenue ($m), 2009-2010 73

Table 43: Interventional Neurology, Canada, Company Share by Revenue ($m), 2009-2010 75

Table 44: Neurological Diagnostic Equipment, Canada, Company Share by Revenue ($m), 2009-2010 77

Table 45: Neurostimulation Devices, Canada, Company Share by Revenue ($m), 2009-2010 79

Table 46: Neurosurgical Products, Canada, Company Share by Revenue ($m), 2009-2010 81

Table 47: Radiosurgery, Canada, Company Share by Revenue ($m), 2009 82

Table 48: Neurology Devices Market Pipeline Products 94

Table 49: Impulse Monitoring Acquires Great Lakes Intraoperative Neuromonitoring 101

Table 50: Boston Scientific Acquires Remaining Stake In Intelect Medical 102

Table 51: Vycor Medical Completes Acquisition Of NovaVision 104

Table 52: Synthes Acquires The Anspach Effort 105

Table 53: Stryker Acquires Porex Surgical 106

Table 54: Cardinal Health Sells 13.7% Stake In Carefusion 107

Table 55: HealthMed Services Acquires Neural Communicator 108

Table 56: Masimo Completes Acquisition Of SEDLine 109

Table 57: Johnson & Johnson Completes Acquisition Of Micrus Endovascular 110

Table 58: K-Kitz Acquires Bacterin In Reverse Acquisition 112

Table 59: Medtronic Acquires Axon Systems 113

Table 60: Covidien Completes Acquisition Of ev3 For $2.6 Billion 114

Table 61: Boston Scientific Enters Into Partnership With Greatbatch Medical 116

Table 62: Synergetics USA Enters Into Co-Development Agreement With Retinal Solutions 117

Table 63: EndoStim Enters Into An Agreement With Arizona State University 118

Table 64: USD to Local Currency, North America, Average Exchange Rate 2003-2010 160

1.2 List of Figures

Figure 1: Neurology Devices, Cross Country Comparison, Revenue ($m), 2003-2017 14

Figure 2: Neurology Devices, North America, Overall Revenue ($m), 2003-2017 15

Figure 3: Neurology Devices, North America, Cross-Category Analysis, 2003-2017 17

Figure 4: Neurology Devices, North America, Overall Revenue ($m), Historic, 2003-2010 18

Figure 5: Neurology Devices, North America, Overall Revenue ($m), Forecast, 2010-2017 20

Figure 6: Neurology Devices, North America, Category Volume (Units), 2003-2017 22

Figure 7: Neurology Devices, North America, Category Volume (Units), Historic, 2003-2010 23

Figure 8: Neurology Devices, North America, Category Volume (Units), Forecast, 2010-2017 25

Figure 9: Neurology Devices, North America, Company share (%), 2010 27

Figure 10: Neurology Devices, United States, Overall Revenue ($m), 2003-2017 29

Figure 11: Neurology Devices, United States, Overall Revenue ($m), Historic, 2003-2010 31

Figure 12: Neurology Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 33

Figure 13: Neurology Devices, United States, Category Volume (Units), 2003-2017 35

Figure 14: Neurology Devices, United States, Category Volume (Units), Historic, 2003-2010 36

Figure 15: Neurology Devices, United States, Category Volume (Units), Forecast, 2010-2017 38

Figure 16: Neurology Devices, United States, Company Share (%), 2010 44

Figure 17: CSF Management, United States, Company Share (%), 2010 46

Figure 18: Interventional Neurology, United States, Company Share (%), 2010 47

Figure 19: Neurological Diagnostic Equipment, United States, Company Share (%), 2010 49

Figure 20: Neurostimulation Devices, United States, Company Share (%), 2010 51

Figure 21: Neurosurgical Products, United States, Company Share (%), 2010 53

Figure 22: Radiosurgery, United States, Company Share (%), 2010 55

Figure 23: Neurology Devices, Canada, Overall Revenue ($m), 2003-2017 56

Figure 24: Neurology Devices, Canada, Overall Revenue ($m), Historic, 2003-2010 58

Figure 25: Neurology Devices, Canada, Overall Revenue ($m), Forecast, 2010-2017 60

Figure 26: Neurology Devices, Canada, Category Volume (Units), 2003-2017 62

Figure 27: Neurology Devices, Canada, Category Volume (Units), Historic, 2003-2010 63

Figure 28: Neurology Devices, Canada, Category Volume (Units), Forecast, 2010-2017 65

Figure 29: Neurology Devices, Canada, Company Share (%), 2010 70

Figure 30: CSF Management, Canada, Company Share (%), 2010 72

Figure 31: Interventional Neurology, Canada, Company Share (%), 2010 74

Figure 32: Neurological Diagnostic Equipment, Canada, Company Share (%), 2010 76

Figure 33: Neurostimulation Devices, Canada, Company Share (%), 2010 78

Figure 34: Neurosurgical Products, Canada, Company Share (%), 2010 80

Figure 35: Medtronic, Inc., Company Share (%), North America Neurology Devices Market, 2010 83

Figure 36: Boston Scientific Corporation, Company Share (%), North America Neurology Devices Market, 2010 84

Figure 37: St. Jude Medical, Inc., Company Share (%), North America Neurology Devices Market, 2010 85

Figure 38: Cyberonics, Inc., Company Share (%), North America Neurology Devices Market, 2010 86

Figure 39: DePuy, Inc., Company Share (%), North America Neurology Devices Market, 2010 87

Figure 40: Integra LifeSciences Holdings Corporation, Company Share (%), North America Neurology Devices Market, 2010 88

Figure 41: CareFusion Corporation, Company Share (%), North America Neurology Devices Market, 2010 89Medtronic, Inc.

Boston Scientific Corporation

St. Jude Medical, Inc.

Cyberonics, Inc.

DePuy, Inc.

Integra LifeSciences Holdings Corporation

CareFusion Corporation

Accuray Incorporated

Cadwell Laboratories, Inc.

Covidien plc

Natus Medical Incorporated

ev3 Inc.

Elekta AB

Micrus Endovascular Corporation

B. Braun Melsungen AG

Terumo Corporation

Nihon Kohden Corporation

KARL STORZ GmbH & Co. KG

Sophysa S.A.

To order this report:

: North America Neurology Devices Market Outlook to 2017

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Contact:
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker